We are live on ! Find out more
TCM

Tygh Capital Management Portfolio holdings

AUM $782M
1-Year Est. Return 39.44%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$13.2M
Cap. Flow
-$5.92M
Cap. Flow %
-1.34%
Top 10 Hldgs %
21.02%
Holding
110
New
19
Increased
34
Reduced
34
Closed
23

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$6.63M
2
AYX
Alteryx Inc
AYX
+$6M
3
ACIW icon
ACI Worldwide
ACIW
+$5.54M
4
ENV
ENVESTNET, INC.
ENV
+$5.4M
5
SIMO icon
Silicon Motion
SIMO
+$5.23M

Top Sells

Rank Stock Value
1
VEEV icon
Veeva Systems
VEEV
+$11.1M
2
TTWO icon
Take-Two Interactive
TTWO
+$7.54M
3
RP
RealPage, Inc.
RP
+$6.76M
4
TSEM icon
Tower Semiconductor
TSEM
+$6.15M
5
AIRM
Air Methods Corp
AIRM
+$5.83M

Sector Composition

Rank Sector Weight
1 Technology 29.75%
2 Industrials 25.41%
3 Consumer Discretionary 13.15%
4 Healthcare 12.22%
5 Financials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTZ icon
1
MasTec
MTZ
$19.4B
$13.3M 3.01%
293,916
+79,349
+37% +$3.43M
LITE icon
2
Lumentum
LITE
$80.3B
$12.3M 2.8%
216,121
-32,712
-13% -$1.75M
DY icon
3
Dycom Industries
DY
$8.88B
$10.4M 2.37%
116,679
-2,006
-2% -$195K
KNSL icon
4
Kinsale Capital Group
KNSL
$8.67B
$8.8M 1.99%
235,807
-5,109
-2% -$180K
TLND
5
DELISTED
Talend S.A. American Depositary Shares
TLND
$8.56M 1.94%
246,131
+38,512
+19% +$1.26M
PTC icon
6
PTC
PTC
$17.1B
$8.5M 1.93%
154,212
+21,972
+17% +$1.21M
BIO icon
7
Bio-Rad Laboratories Class A
BIO
$10.4B
$8.02M 1.82%
35,456
+4,461
+14% +$972K
HEI icon
8
HEICO Corp
HEI
$47B
$7.96M 1.8%
216,393
+59,830
+38% +$2.2M
AFAM
9
DELISTED
Almost Family Inc
AFAM
$7.51M 1.7%
121,771
+6,200
+5% +$339K
NEWR
10
DELISTED
New Relic, Inc.
NEWR
$7.32M 1.66%
170,078
+45,243
+36% +$1.88M
PATK icon
11
Patrick Industries
PATK
$2.68B
$7.24M 1.64%
223,709
+102,668
+85% +$3.2M
TSEM icon
12
Tower Semiconductor
TSEM
$23.5B
$7.19M 1.63%
301,649
-260,820
-46% -$6.15M
LGND icon
13
Ligand Pharmaceuticals
LGND
$5.59B
$7.18M 1.63%
+94,825
New +$6.63M
EXP icon
14
Eagle Materials
EXP
$6.06B
$7.09M 1.61%
76,686
+16,252
+27% +$1.56M
AYX
15
DELISTED
Alteryx Inc
AYX
$6.9M 1.56%
353,590
+333,590
+1,668% +$6M
SUM
16
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$6.88M 1.56%
245,656
+69,825
+40% +$1.82M
GWR
17
DELISTED
Genesee & Wyoming Inc.
GWR
$6.82M 1.55%
99,733
-1,883
-2% -$124K
XPO icon
18
XPO
XPO
$22.1B
$6.65M 1.51%
297,600
+51,146
+21% +$958K
SXI icon
19
Standex International
SXI
$3.62B
$6.53M 1.48%
71,984
+27,069
+60% +$2.46M
HMSY
20
DELISTED
HMS Holdings Corp.
HMSY
$6.5M 1.47%
351,333
+78,047
+29% +$1.5M
CVSA
21
Covista Inc
CVSA
$4.58B
$6.35M 1.44%
167,294
-2,871
-2% -$107K
VIAV icon
22
Viavi Solutions
VIAV
$9.02B
$6.31M 1.43%
599,273
+458,797
+327% +$4.94M
JBTM
23
JBT Marel
JBTM
$6.14B
$6.3M 1.43%
64,321
+3,717
+6% +$330K
MSCC
24
DELISTED
Microsemi Corp
MSCC
$6.19M 1.4%
132,256
+13,197
+11% +$646K
PENN icon
25
PENN Entertainment
PENN
$2.33B
$6.18M 1.4%
288,622
+21,999
+8% +$433K
1
2 3 4 5

Similar funds

IVP
IA Venture Partners New York $785M AUM
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
EHPM
Emery Howard Portfolio Management Burlingame, California $773M AUM 18.85% 1-Year Est. Return
VMV
Venrock Management V Palo Alto, California $719M AUM
SIM
SCGF III Management Menlo Park, California $673M AUM
HAM
Hillcrest Asset Management Plano, Texas $656M AUM 31.12% 1-Year Est. Return
VIMU
Veritas Investment Management (UK) London, United Kingdom $648M AUM 36.52% 1-Year Est. Return
AC
Alley Company Lake Forest, Illinois $631M AUM 24.9% 1-Year Est. Return

Tygh Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Tygh Capital Management held 110 positions worth $441M, up 3.1% from $428M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tygh Capital Management's Q2 2017 filing shows 19 new, 34 increased, 34 reduced and 23 closed positions. Its largest new stake was Ligand Pharmaceuticals: 94,825 shares worth $7.18M. The largest sale was Veeva Systems, an estimated $11.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Tygh Capital Management's largest Q2 2017 buy was Ligand Pharmaceuticals: 94,825 shares worth $7.18M.
  • Tygh Capital Management added most to Alteryx Inc in Q2 2017, an estimated $6M increase.
  • Tygh Capital Management's biggest Q2 2017 reduction was Take-Two Interactive, cutting an estimated $7.54M.
  • Tygh Capital Management fully exited Veeva Systems in Q2 2017, selling an estimated $11.1M.
  • Tygh Capital Management's ten largest holdings make up 21% of its $441M portfolio in Q2 2017.
  • Tygh Capital Management opened 19 new positions and closed 23 in Q2 2017.
  • Tygh Capital Management's portfolio value rose 3.1% quarter-over-quarter to $441M.

Based on Tygh Capital Management's 13F filing for Q2 2017, filed 7 Aug 2017.